Young children with type 1 diabetes: challenges, research, and future directions

Related Experiment Video

Updated: Apr 27, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.6K

Randi Streisand1, Maureen Monaghan

  • 1Center for Translational Science, Children's National Health System, 111 Michigan Ave NW, Washington, DC, 20010, USA, rstreis@childrensnational.org.

Current Diabetes Reports
|July 11, 2014
PubMed

Insights

Type 1 diabetes (T1D) management in young children (<6 years) is challenging due to unpredictable behavior and physiological difficulties. Specialized care and research are needed for this growing population.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Child Psychology

Background:

  • Rising incidence of type 1 diabetes (T1D) in children under 6 years.
  • Current diabetes management guidelines place a significant burden on caregivers of young children.
  • Unique physiological and behavioral challenges in managing T1D in early childhood.

Purpose of the Study:

  • To review existing research on T1D in young children.
  • To discuss clinical implications for managing T1D in this age group.
  • To identify areas for future research in pediatric T1D.

Main Methods:

  • Literature review of research findings on type 1 diabetes in young children.
  • Analysis of clinical management challenges and caregiver burden.
  • Discussion of developmental and behavioral factors influencing T1D control.

Main Results:

  • Limited scope and quantity of behavioral research specific to young children with T1D.
  • Significant caregiver stress and strain due to intensive management requirements.
  • Physiological and behavioral unpredictability complicates glycemic control in this age group.

Conclusions:

  • Young children with T1D have distinct management needs not adequately addressed by current services.
  • Specialized education and clinical support are crucial for caregivers and children.
  • Further research is essential to improve T1D care for the pediatric population.

More Related Videos

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

2.1K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.1K

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
40
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
57
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
19
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
13
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K